Lobbying disclosures · Lobbying report
AGIO: third_quarter 2026 lobbying report
Issues related to prescription drugs
Follow AGIO- Became public
- Oct 18, 2026, 9:19 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 6:38 AM EST
Why this is connected
Exact legal-name match: AGIOS PHARMACEUTICALS, INC. (https://www.sec.gov/Archives/edgar/data/1439222/).
Reported lobbying amounts
Income: $10,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/0b698e01-9693-42b3-9264-0e5b84a5d526/","filing_uuid":"0b698e01-9693-42b3-9264-0e5b84a5d526","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/0b698e01-9693-42b3-9264-0e5b84a5d526/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"JEFFREY J. KIMBELL","dt_posted":"2026-10-18T21:19:55-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"401 9th Street NW","registrant_address_2":"Suite 920","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":46038,"url":"https://lda.gov/api/v1/registrants/46038/","house_registrant_id":34381,"name":"JEFFREY J. KIMBELL & ASSOCIATES, INC.","description":"Consulting Firm","address_1":"401 9th Street NW","address_2":"Suite 920","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY KIMBELL","contact_telephone":"+1 202-735-2590","dt_updated":"2026-10-19T16:46:08.608430-04:00"},"client":{"id":70491,"url":"https://lda.gov/api/v1/clients/70491/","client_id":70491,"name":"AGIOS PHARMACEUTICALS, INC.","general_description":"rare disease focused biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-24"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to prescription drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":42442,"prefix":"mr","prefix_display":"MR.","first_name":"JEFFREY","nickname":null,"middle_name":"J","last_name":"KIMBELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53650,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"HERZOG","suffix":null,"suffix_display":null},"covered_position":"Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President","new":false},{"lobbyist":{"id":60159,"prefix":null,"prefix_display":null,"first_name":"KEITH","nickname":null,"middle_name":null,"last_name":"STUDDARD","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Marsha Blackburn","new":false},{"lobbyist":{"id":149308,"prefix":null,"prefix_display":null,"first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"KEMPER","suffix":null,"suffix_display":null},"covered_position":"Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services","new":false},{"lobbyist":{"id":139878,"prefix":"mr","prefix_display":"MR.","first_name":"KENNETH","nickname":null,"middle_name":"LEE","last_name":"HODGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67296,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"R","last_name":"RAY","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Mike Kelly","new":false},{"lobbyist":{"id":150293,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"MEEKS","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander","new":false},{"lobbyist":{"id":68519,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"RUDLOFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153987,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"FRITSCH","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce","new":true},{"lobbyist":{"id":155140,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"PEREZ","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":true},{"lobbyist":{"id":155141,"prefix":null,"prefix_display":null,"first_name":"COOPER","nickname":null,"middle_name":null,"last_name":"CHAMBLEE","suffix":null,"suffix_display":null},"covered_position":"Intern, Sen. Tim Scott","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in AGIO
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 10, 2026
- Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Mar 3, 2026 · disclosed Apr 7, 2026
- Jan 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Dec 11, 2025 · disclosed Jan 12, 2026
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Apr 17, 2025 · disclosed May 6, 2025
- Feb 11, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Jan 29, 2025 · disclosed Feb 11, 2025
- Feb 15, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Agios Pharmaceuticals AGIO
$1K–$15K · Traded Jan 24, 2024 · disclosed Feb 15, 2024 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.